0001415889-23-003054.txt : 20230222
0001415889-23-003054.hdr.sgml : 20230222
20230222185845
ACCESSION NUMBER: 0001415889-23-003054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230217
FILED AS OF DATE: 20230222
DATE AS OF CHANGE: 20230222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karam Sammy
CENTRAL INDEX KEY: 0001766718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 23655262
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02222023_110235.xml
X0306
4
2023-02-17
0000001800
ABBOTT LABORATORIES
ABT
0001766718
Karam Sammy
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
SENIOR VICE PRESIDENT
Option (right to buy)
106.24
2023-02-17
4
A
0
45812
0
A
2024-02-17
2033-02-16
Common Shares
45812
45812
D
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,270 on February 17, 2024, 15,271 on February 17, 2025, and 15,271 on February 17, 2026.
/s/ Sammy Karam by Jessica H. Paik, Attorney-in-Fact
2023-02-22